Skip to content

Progestogen-only hormonal contraception linked to metabolic problems in HIV-positive women

Bone loss following onset of menopause may put HIV-positive women at risk for fractures

Women who start ART in pregnancy do just as well as non-pregnant women

Switching from efavirenz to nevirapine in women with higher CD4 counts

Hormonal contraception does not affect HIV progression in large international cohort

HIV treatment for mothers and children in Botswana: lessons from a dynamic programme

Women and girls must have equal access to HIV treatment, say WHO and UNAIDS

Hormonal contraceptives increase cervical infections in HIV-positive women: implications for disease progression and HIV transmission

Women at greatest risk of NNRTI rash